Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-002644
Filing Date
2012-03-14
Accepted
2012-03-14 17:24:16
Documents
17
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2207639z10-k.htm 10-K 1405128
2 EX-21.1 a2207639zex-21_1.htm EX-21.1 3821
3 EX-23.1 a2207639zex-23_1.htm EX-23.1 3414
4 EX-31.1 a2207639zex-31_1.htm EX-31.1 8089
5 EX-31.2 a2207639zex-31_2.htm EX-31.2 8100
6 EX-32.1 a2207639zex-32_1.htm EX-32.1 5424
7 EX-32.2 a2207639zex-32_2.htm EX-32.2 5483
14 G511773.JPG g511773.jpg GRAPHIC 16444
15 G240279.JPG g240279.jpg GRAPHIC 44715
16 G601239.JPG g601239.jpg GRAPHIC 33391
17 G264584.JPG g264584.jpg GRAPHIC 64638
  Complete submission text file 0001047469-12-002644.txt   5127841

Data Files

Seq Description Document Type Size
8 EX-101.INS anth-20111231.xml EX-101.INS 594468
9 EX-101.SCH anth-20111231.xsd EX-101.SCH 34532
10 EX-101.CAL anth-20111231_cal.xml EX-101.CAL 84321
11 EX-101.DEF anth-20111231_def.xml EX-101.DEF 134321
12 EX-101.LAB anth-20111231_lab.xml EX-101.LAB 462847
13 EX-101.PRE anth-20111231_pre.xml EX-101.PRE 188226
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

EIN.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34637 | Film No.: 12691165
SIC: 2834 Pharmaceutical Preparations